Bicycle Therapeutics

Bicycle Therapeutics is a biopharmaceutical company focused on developing precision-guided therapeutics, known as Bicycles, to target intractable cancers and other unmet medical needs. Bicycles are unique bi-cyclic peptides that can penetrate deep into tissues and effectively mimic protein-protein interactions, allowing for the targeting of hard-to-drug targets. These molecules combine the pharmacological properties of biologics with the advantages of small molecules, enabling rapid tissue penetration and precise delivery to disease tissues. The company's innovative approach has led to the development of various therapeutic candidates, including Bicycle Toxin Conjugates and Bicycle Radio Conjugates, designed to target specific tumor antigens and immune cell agonists for tumor treatment.